| SBT Pipeline | Development Stage | Therapeutic | Indication | Research | Preclinical | Phase 1 | Comments |
|---|---|---|---|---|---|
| SBT-102 (KRAS) | Pancreatic Cancer |
|
2024 | Tested In Vitro | |
| Colorectal Cancer |
|
||||
| Lung (NSCLC) Cancer |
|
||||